Dictionary

allow_url_fopen is ENABLED Dictionary Search

remicade

Synonyms

Noun

1. infliximab

2. Remicade, anti-TNF compound

Usage
Demand for Remicade Biosimilar in USA | Global Market Analysis Report - 2035 - Future Market Insights
How Long Does Remicade Take to Work for Ulcerative Colitis? - HealthCentral
Celltrion expands US market reach as Zymfentra and Inflectra secure major formulary listings - koreabiomed.com
Zymfentra Launch: Here’s How to Switch to Zymfentra - GoodRx
Methotrexate is safer second-line sarcoidosis treatment than MMF - Sarcoidosis News
The Biosimilar Shift: Trending Infliximab Biosimilar Utilization and Associated Cost Savings for Commercial Insurance - AJMC
Implications of the First Liquid IV Infliximab Biosimilar - BioPharm International
Q&A: Remicade treatment weakens COVID-19 antibody response in IBD - Healio
UC Remission: Is Combination Therapy the Key? - WebMD
Remicade and pregnancy, breastfeeding, and more - Medical News Today
FDA Approves First Subcutaneous Infliximab Product - Center for Biosimilars
Inflectra, a Remicade Biosimilar, Now Available Through Medicare and Medicaid - Arthritis Foundation
Biosimilar drugs gain ground in U.S., but concerns linger about when patients can switch - statnews.com
Remicade Class Action Suit Settled by J&J - Anton Health
FDA SIDE EFFECTS UPDATE: Remicade and the Onset of New Autoimmune Diseases, Plus More - MedShadow Foundation
J&J unfazed by falling Remicade sales - BioPharma Dive
Biosimilars of infliximab - Generics and Biosimilars Initiative
Which Biologics Treat Ulcerative Colitis (UC)? - GoodRx
Corticosteroid Premedication for Infliximab Remains Unnecessarily Common - AJMC
Study: Remicade effective for sarcoidosis of nerves or liver, not muscles, skin - Sarcoidosis News
In VA Study, Many Patients Who Tried Biosimilar Infliximab Went Back to Remicade - Center for Biosimilars
University of North Carolina Study Finds Infliximab Biosimilars Comparable to Remicade in Gastroenterology and Rheumatology Clinics - Managed Healthcare Executive
J&J's Stelara clinches ulcerative colitis nod to back up declining Remicade - Fierce Pharma
FDA Approves Amgen's AVSOLA™ (infliximab-axxq), For The Same Indications As Remicade® (infliximab) - Amgen
FLIXABI®, an Infliximab Biosimilar Candidate Referencing Remicade®, Receives Positive CHMP Opinion - Biogen
Treating IBD with Humira, Remicade May Increase Risk of Kidney Damage: Study - AboutLawsuits.com
One of the world’s blockbuster drugs might not exist if its research hadn't flopped in a major way - Business Insider
FTC probing J&J on Remicade, as biosimilar market remains muted - BioPharma Dive
J&J offered doctors free services and profit-making advice to boost Remicade scripts: whistleblower suit - Fierce Pharma
Which Biologic Is Best for Uveitis in Behcet’s Disease? What a New Study Found - CreakyJoints
Mass spectrometry comparison of Remicade and Remsima - Generics and Biosimilars Initiative
J&J keeping Remicade biosimilars at bay through price drops - BioProcess International
Zymfentra, a Subcutaneous Formulation of Infliximab, Approved for IBD - Medical Professionals Reference
Remicade: A Case Study in How U.S. Pricing and Reimbursement Curb Adoption of Biosimilars (rerun) - Drug Channels
Comparison of WAC of Remicade vs biosimilars in the U.S. as of Q1 2026 - Statista
J&J Settles Pfizer's Antitrust Suit Over Remicade Biosimilar - Law360
Crohn's disease medication: What if they stop working? - Medical News Today
Development of Anti-Drug Antibodies to Infliximab (Remicade®) and Adalimumab (Humira®) in Patients With Crohn’s Disease - 2 Minute Medicine
Johnson & Johnson Loses Remicade Patent in Appeal Ruling - Bloomberg
FDA approves Avsola, fourth Remicade biosimilar - Healio
Pfizer is taking its fight with J&J over a blockbuster drug to court - Business Insider
How did Johnson & Johnson beat back Remicade's biosim? Call it the art of the deal - Fierce Pharma
Pfizer Alleges J&J Thwarted Competition to Remicade, in Legal Test of Biotech-Drug Copies - WSJ
Remicade, Stelara have similar speed of onset in Crohn’s - Healio
Johnson & Johnson falls short in a Remicade patent case as star drug slips in Q4 - Fierce Pharma
Pfizer Resolves Antitrust Lawsuit With J&J Over Remicade - Center for Biosimilars
Johnson & Johnson's Stelara, Tremfya step up in Q4 as Remicade's decline speeds - Fierce Pharma
J&J: Remicade holding up better than expected - BioPharma Dive
Merck lowers cost of Remicade in UK as biosimilars enter market - BioPharma Dive
J&J boasted about defending Remicade from biosims. Now it's under FTC investigation - Fierce Pharma
Should I Switch My Rheumatoid Arthritis Meds? A Patient Weighs the Pros and Cons - CreakyJoints
Study: Many Ankylosing Spondylitis Patients Who Stop Taking Infliximab (Remicade) Wind Up Relapsing - CreakyJoints
FLIXABI®, Biogen’s Infliximab Biosimilar Referencing Remicade®, Approved in the European Union - Biogen
J&J braces for biosim attack after losing last-ditch Remicade patent fight - Fierce Pharma
Pfizer accuses Johnson & Johnson of 'anticompetitive practices' in lawsuit - USA Today
Remicade copy clears FDA, becomes second biosim to win approval in U.S. - BioPharma Dive
Remicade Biosimilar Market to Reach USD 4.01 Billion By 2035 At a 5.4% CAGR, Driven By Rising Demand For Cost-Effective Autoimmune Treatments | FMI - Yahoo Finance
What Happens When an Anti-TNF Fails for RA - Arthritis Foundation
Pfizer's second biosimilar of J&J's Remicade wins U.S. FDA approval - Reuters
As Johnson & Johnson holds off U.S. biosims, Remicade's European market share falls to 50%: report - Fierce Pharma
Remicade: A Case Study in How U.S. Pricing and Reimbursement Curb Adoption of Biosimilars - Drug Channels
Discontinuation of Infliximab Therapy in Patients with Crohn’s Disease - NEJM Evidence
Second biosimilar of Remicade approved in the US, but J&J not rattled - BioPharma Dive
Treating IBD During Pregnancy - Johns Hopkins Medicine
Celltrion Wins FDA Approval for First Subcutaneous Version of IBD Drug Infliximab - BioSpace
FDA Approves Inflectra, Biosimilar to Remicade - Gastroenterology & Endoscopy News
Want to Switch Back to a Biologic IBD Drug After Taking a Biosimilar? New Study Says It's Safe - CreakyJoints
Merck undercuts Pfizer on Remicade biosimilar price - BioPharma Dive
Celltrion taps Intract Pharma to develop world's first oral Remicade biosimilar - Fierce Pharma
The Medical Minute: Biosimilars for your IBD? Nothing to fear here! - Penn State Health News
FDA OK’s new Remicade copycat but no launch planned - BioPharma Dive
J&J abandons Remicade patent fight against Samsung and its Renflexis biosim - Fierce Pharma
The Man Who Discovered Remicade Is All for Biosimilars - Business Insider
Top stories in gastroenterology: Ibsrela improves symptoms of IBS subtype, Remicade best for biologic-naive ulcerative colitis - Healio
Lack of Interchangeable Biosimilars Keeps J&J in the Infliximab Game - BioProcess International
Pfizer, Johnson & Johnson Settle Antitrust Suit Over Remicade - Bloomberg Law News
J&J says ready to fend off Remicade competitor - pharmaphorum
Remicade (infliximab) antitrust $25M class action settlement - Class Action Lawsuits
Celltrion submits FDA filing for biosimilar Remicade - BioPharma Dive
Samsung Targets U.S. Drug Market With Remicade Knockoff - WSJ
Celltrion taps Lonza to produce some of its Remicade biosimilar - BioPharma Dive
FDA approves infliximab biosimilar Ixifi for all of Remicade’s indications - MDEdge
Remicade Lawsuits - AboutLawsuits.com
Pfizer sues J&J over Remicade contracts - BioPharma Dive
FDA Approves First Subcutaneous Infliximab for IBD - Managed Healthcare Executive
When Patients Develop Antibodies to TNF Inhibitors - MedCentral
Merck Announces US Launch of Biosimilar Infliximab Renflexis - Center for Biosimilars
Pfizer, Johnson & Johnson settle high-profile Remicade biosim lawsuit on undisclosed terms - Fierce Pharma
Big deal for biosims? Major French hospital group opts for Hospira’s Remicade copy - BioPharma Dive
What’s It Like Having COVID When You’re Immunocompromised — and What I’m Still Worried About - CreakyJoints
FDA staff sounds encouraging note on Celltrion’s biosim of J&J blockbuster Remicade - BioPharma Dive
Biosimilar Drugs Are Cheaper Than Biologics. Are They Similar Enough To Switch? - The Lund Report
Celltrion drug Remsima SC has potential to erode Remicade shares - Pharmaceutical Technology
Weight Gain on Infliximab Tied to Sex, Crohn Disease, and Disease Severity - Gastroenterology Advisor
J&J faces FTC probe on Remicade biosimilar defence - pharmaphorum
Pfizer Plans to Launch Remicade Biosimilar in November - WSJ
Switching Back to Originator From Biosimilar Infliximab Results in Higher Discontinue Rates - AJMC
Remicade biosimilars hit European market - PMLiVE
Biogen launches Remicade biosimilar in the UK - PMLiVE
After strong FDA panel backing, Celltrion & Pfizer's Remicade copycat could become 2nd US biosim - BioPharma Dive
Foreign Language Equivalents
Foreign Language Equivalents of 'remicade'
Language Equivalent   Language Equivalent
French    Spanish
Misspellings - Typos
remocade,   remicsde,   remicae,   eemicade,   remcade,   remmicade,   remicase,   temicade,   remicaade,   remicad,   rremicade,   remiicade,   reimcade,   reicade,   remicadde,   remicde,   remiade,   re,icade,   remivade,   remicadr,   remciade,   remicdae,   remicafe,   rmicade,   emicade,   remixade,   remiccade,   remicadee,   remucade,   rrmicade,   remiacde,   renicade,   rmeicade,   remicaed,   rwmicade,   ermicade,   reemicade,   remicadw
Words Starting with Letter - 'A'
a a battery a billion
a bit a bit much a capella singing
a cappella singing a couple of a few
a fortiori a good deal a great deal
a horizon a hundred a hundred and one
a hundred thousand a hundred times a kempis
a la carte a la mode a level
a little a lot a million
Go to Page 1              Go to Page 2 »   
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z